Clinical Trials Browser

Withdrawn × temsirolimus × Gastrointestinal × Clear all

NCT01335074 2016-11-15

Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT01281943 2013-07-04

Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer

Phase 2 Withdrawn

Gastrointestinal

Liver Neoplasms